Japanese lab buys 4-tesla scanner

Article

Varian Associates of Palo Alto, CA, has sold the most powerfulwhole-body MRI scanner ever to be acquired by a Japanese laboratory. A Varian 4-tesla scanner will be installed this month at theInstitute of Physical and Chemical Research (RIKEN) in Wako

Varian Associates of Palo Alto, CA, has sold the most powerfulwhole-body MRI scanner ever to be acquired by a Japanese laboratory.

A Varian 4-tesla scanner will be installed this month at theInstitute of Physical and Chemical Research (RIKEN) in Wako City,Japan. It will be operated under the direction of Dr. Keiji Tanaka,head of RIKEN's neural information processing laboratory, to studybrain functions, such as recognition, memory, and motor programming.

The $4 million system consists of Varian's Unity Inova spectrometerand a magnet and gradient coils supplied by Siemens Medical Systems.It is the second 4-tesla scanner built by Varian since the companyreentered the ultra-high-field MRI manufacturing sector in 1995(SCAN 3/27/96). The other system was installed in Canada in Marchat Robarts Research Institute in London, Ontario.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.